Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeTax ProvisionsTax Rate
Others
Ratios

iHuman (IH) EPS (Weighted Average and Diluted) (2020 - 2024)

Historic EPS (Weighted Average and Diluted) for iHuman (IH) over the last 5 years, with Q4 2024 value amounting to $0.72.

  • iHuman's EPS (Weighted Average and Diluted) fell 2306.51% to $0.72 in Q4 2024 from the same period last year, while for Dec 2024 it was $2.69, marking a year-over-year increase of 18859.6%. This contributed to the annual value of $2.69 for FY2024, which is 4533.3% down from last year.
  • iHuman's EPS (Weighted Average and Diluted) amounted to $0.72 in Q4 2024, which was down 2306.51% from $0.93 recorded in Q4 2023.
  • In the past 5 years, iHuman's EPS (Weighted Average and Diluted) registered a high of $1.07 during Q4 2022, and its lowest value of -$1.58 during Q4 2020.
  • Over the past 5 years, iHuman's median EPS (Weighted Average and Diluted) value was $0.56 (recorded in 2022), while the average stood at $0.17.
  • Its EPS (Weighted Average and Diluted) has fluctuated over the past 5 years, first surged by 79616.33% in 2022, then plummeted by 2306.51% in 2024.
  • Over the past 5 years, iHuman's EPS (Weighted Average and Diluted) (Quarter) stood at -$1.58 in 2020, then skyrocketed by 90.34% to -$0.15 in 2021, then skyrocketed by 796.16% to $1.07 in 2022, then fell by 12.65% to $0.93 in 2023, then fell by 23.07% to $0.72 in 2024.
  • Its last three reported values are $0.72 in Q4 2024, $0.93 for Q4 2023, and $1.07 during Q4 2022.